Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

17.20
-1.0761-5.89%
Volume:4K
Turnover:77.33K
Market Cap:1.61B
PE:-7.39
High:17.78
Open:17.78
Low:17.19
Close:18.28
52wk High:42.47
52wk Low:16.36
Shares:93.33M
Float Shares:71.58M
Volume Ratio:1.35
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3260
EPS(LYR):-1.9957
ROE:-236.63%
ROA:-28.04%
PB:19.39
PE(LYR):-8.62

Loading ...

Oppenheimer Keeps Their Buy Rating on Ascentage Pharma Group International Unsponsored ADR (AAPG)

TIPRANKS
·
Aug 21

Ascentage Pharma H1 Loss Widens, Revenue Rises

MT Newswires Live
·
Aug 20

Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate

Benzinga Earnings
·
Aug 20

Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion

Stock News
·
Aug 20

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

GlobeNewswire
·
Aug 20

Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit

GlobeNewswire
·
Aug 13

Earning Preview: ASCENTAGE PHARMA GROUP this quarter’s revenue is expected to increase by 58.18%, and institutional views are bullish

Earnings Agent
·
Aug 12

CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

GlobeNewswire
·
Aug 05

Ascentage Pharma appoints Miyara as CBO, Ziegler as CCO

TIPRANKS
·
Aug 03

ASCENTAGE PHARMA GROUP Appoints Two Key Executives to Lead Global Business and Commercial Operations

Stock News
·
Aug 03

Press Release: Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer

Dow Jones
·
Aug 03

Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026

GlobeNewswire
·
Jul 27

Ascentage Pharma files to sell American Depositary Shares, no amount given

TIPRANKS
·
Jul 20

ASCENTAGE PHARMA Announces Grant of 440,700 Restricted Share Units Under 2021 Plan

Stock News
·
Jun 30

Ascentage Pharma announces clinical updates from EHA2026

TIPRANKS
·
Jun 15

ASCENTAGE PHARMA GROUP (ASX: 06855) Discloses Multiple Clinical Advances at 2026 European Hematology Association Congress

Stock News
·
Jun 15

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

GlobeNewswire
·
Jun 15

ASCENTAGE PHARMA Group Acquires 110,000 Shares for 2022 Restricted Stock Unit Plan

Stock News
·
Jun 11

ASCENTAGE PHARMA GROUP Acquires 190,000 Shares Under 2022 Restricted Share Unit Plan

Stock News
·
Jun 10

Ascentage Pharma initiated with a Buy at B. Riley

TIPRANKS
·
Jun 10